韩日免费视频,国产盗摄视频在线观看,精品一区二区三区四区在线

熱門搜索化學品最多只顯示前20條，請點擊“搜索化學品”查看所有結(jié)果

CAS登錄號

中文名

英文名

分子結(jié)構(gòu)式

分子式

詳情

供應(yīng)商

103476-89-7

亮抑酶肽;
亮肽素

LeuPeptin;
Acetyl-L-leucyl-L-leucyl-L-argininal hemisulfate;
LeuPeptin hemisulfate salt

2(C20H38N6O4).H2SO4

詳情

供應(yīng)商

108736-35-2

蘭瑞肽

Lanreotide;
AngioPeptin;
3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-7)-disulfide

人α-ANF(I-28)

Atrial natriureticpeptide-28 (human reduced) (9CI);
AtrioPeptin-33(rat reduced), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-;
13: PN: WO2004089280 SEQID: 13 unclaimed sequence;
13: PN: WO2005103087 SEQID:16 unclaimed sequence;
140: PN: WO2008058016 SEQID: 141 claimed protein;
15:PN: US20030119021 SEQID: 14 unclaimed sequence;
15: PN: WO2008154226 SEQID: 15unclaimed protein;
16: PN: WO0071576 SEQID: 16 unclaimed sequence;
18: PN:WO2004022003 SEQID: 4 claimed sequence;
18: PN: WO2005094420 SEQID: 4 claimedsequence;
19: PN: WO2007034498 SEQID: 18 unclaimed sequence;
1: PN: DE19942230SEQID: 6 claimed protein;
1: PN: US20030069186 SEQID: 5 unclaimed sequence;
1:PN: US20090163421 SEQID: 1 unclaimed sequence;
1: PN: WO0185945 SEQID: 1unclaimed sequence;
2145: PN: WO03060071 SEQID: 2207 unclaimed;
21: PN:WO2004045592 SEQID: 20 unclaimed sequence;
220: PN: US20060293232 PAGE: 14unclaimed sequence;
294: PN: WO0069900 SEQID: 476 unclaimed sequence;
2: PN:GB2403533 SEQID: 2 claimed sequence;
2: PN: WO02074234 FIGURE: 3B claimedprotein;
301: PN: US20080004206 SEQID: 302 unclaimed protein;
313: PN:WO0069900 SEQID: 495 unclaimed sequence;
38: PN: WO2005003296 SEQID: 309unclaimed sequence;
393: PN: US20090175821 SEQID: 476 claimed protein;
3: PN:CN1278007 SEQID: 5 unclaimed sequence;
3: PN: US20080194481 SEQID: 302 claimedprotein;
439: PN: US20080312157 SEQID: 456 unclaimed sequence;
4: PN:US20080214437 SEQID: 4 claimed protein;
4: PN: WO2009073527 SEQID: 4 claimedprotein;
4: PN: WO2009142307 SEQID: 100 claimed protein;
5-32-Urodilatin(human);
59: PN: US6033884 SEQID: 53 unclaimed protein;
5: PN: WO2007035600SEQID: 3 unclaimed sequence;
604: PN: WO2009058322 SEQID: 302 claimed sequence;
78: PN: WO03099862 PAGE: 45 unclaimed protein;
7: PN: US20060183154 SEQID: 7claimed sequence;
95: PN: WO2007047504 SEQID: 179 unclaimed sequence;
99-126-natriuretic hormone peptide (human);
9: PN: US20010027181 SEQID: 1unclaimed protein;
AtrioPeptin-28 (Canis familiaris reduced);

Atrial natriureticpeptide-24 (Rana catesbeiana reduced) (9CI);
AtrioPeptin-21(rat reduced), 2a-endo-L-aspartic acid-6-L-serine-17-L-methionine-20-glycine-21-L-arginine-21a-L-arginine-21b-L-phenylalanine-;
286: PN: WO0069900 SEQID: 468 unclaimed sequence;
289: PN: WO0069900 SEQID: 471unclaimed sequence;
386: PN: US20090175821 SEQID: 468 claimed protein;
3: PN:US20010027181 SEQID: 5 unclaimed sequence;
L-Phenylalanine, L-seryl-L-seryl-L-a-aspartyl-L-cysteinyl-L-phenylalanylglycyl-L-seryl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-arginyl-L-arginyl-

Atrial natriureticpeptide-29 (chicken reduced) (9CI);
AtrioPeptin-29(chicken reduced);
283: PN: WO0069900 SEQID: 465 unclaimed sequence;
383: PN:US20090175821 SEQID: 465 claimed protein;
5: PN: US20010027181 SEQID: 8unclaimed sequence;
L-Asparagine, L-methionyl-L-methionyl-L-arginyl-L-a-aspartyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-leucyl-L-serylglycyl-L-methionylglycyl-L-cysteinyl-L-asparaginylglycyl-L-seryl-L-arginyl-L-lysyl-;
a-AtrioPeptin (chicken reduced)

AdenoPeptin (9CI);
AntibioticPF 1201;
Isovalinamide, 1-acetylprolylisovalylisovalyl-b-alanylglycyl-2-methylalanyl-2-methylalanylisovalyl-2-methylalanyl-2-methylalanyl-2-methylalanyl-2-piperidinecarbonyl-N-[1-[(2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidinium-1-yl)methyl]-3-methylbutyl]-

Arginine,N-acetyl-L-leucyl-L-leucyl- (9CI);
Arginine,N2-[N-(N-acetyl-L-leucyl)-L-leucyl]-, DL- (8CI);
DL-Arginine,N2-[N-(N-acetyl-L-leucyl)-L-leucyl]-;
LeuPeptin Ac-LL acid

Atrial natriureticpeptide-21 (rat reduced) (9CI);
AtrioPeptin-21(rat reduced);
301: PN: WO0069900 SEQID: 483 unclaimed sequence;
400: PN:US20090175821 SEQID: 483 claimed protein;
L-Serine,L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-

Glutamic acid,L-leucyl-3-nitro- (9CI);
Glutamicacid, N-L-leucyl-3-nitro-;
(-)-NitroPeptin;
NitroPeptin

LuzoPeptin C (9CI);
BBM-928 C

詳情

供應(yīng)商

76149-24-1

LuzoPeptin B (9CI);
LuzoPeptinC, 2-acetate;
1H,16H,20H,35H-Dipyridazino[6,1-l:6',1'-b1][1,17,4,7,10,13,20,23,26,29]dioxaoctaazacyclodotriacontine,cyclic peptide deriv.;
2-Quinolinecarboxamide,N,N'-[4-(acetyloxy)-4,4a,5,6,7,8,9,10,11,12,13,14,17,18,23,23a,24,25,26,27,28,29,30,31,32,33,36,37-octacosahydro-23-hydroxy-13,32-bis(1-hydroxy-1-methylethyl)-9,12,28,31-tetramethyl-5,8,11,14,18,24,27,30,33,37-decaoxo-3H,16H,22H,35H-dipyridazino[6,1-l:6',1'-b1][1,17,4,7,10,13,20,23,26,29]dioxaoctaazacyclodotriacontine-17,36-diyl]bis[3-hydroxy-6-methoxy-,[4S-(4R*,4aR*,13R*,17S*,23R*,23aR*,32R*,36S*)]-;
Antibiotic BBM 928B

L-Leucinamide,N-(1-oxopropyl)-L-leucyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]- (9CI);
Valeramide,N-(1-formyl-4-guanidinobutyl)-4-methyl-2-(4-methyl-2-propionamidovaleramido)-,stereoisomer (8CI);
LeuPeptin Pr-LL;
Propionyl-L-leucyl-L-leucylargininal

L-Tryptophan,N-[[(6-deoxy-a-L-talopyranosyl)oxy]hydroxyphosphinyl]-L-leucyl-;
L-Tryptophan,N-[N-[[(6-deoxy-a-L-talopyranosyl)oxy]hydroxyphosphinyl]-L-leucyl]-;
TaloPeptin

LuzoPeptin A (9CI);
LuzoPeptinC, 2,7-diacetate;
3H,16H,22H,35H-Dipyridazino[6,1-l:6',1'-b1][1,17,4,7,10,13,20,23,26,29]dioxaoctaazacyclodotriacontine,cyclic peptide deriv.;
2-Quinolinecarboxamide,N,N'-[4,23-bis(acetyloxy)-4,4a,5,6,7,8,9,10,11,12,13,14,17,18,23,23a,24,25,26,27,28,29,30,31,32,33,36,37-octacosahydro-13,32-bis(1-hydroxy-1-methylethyl)-9,12,28,31-tetramethyl-5,8,11,14,18,24,27,30,33,37-decaoxo-3H,16H,22H,35H-dipyridazino[6,1-l:6',1'-b1][1,17,4,7,10,13,20,23,26,29]dioxaoctaazacyclodotriacontine-17,36-diyl]bis[3-hydroxy-6-methoxy-,[4S-(4R*,4aR*,13R*,17S*,23R*,23aR*,32R*,36S*)]-;
Antibiotic BBM 928A;
BBM 928A

L-Leucinamide,N-acetyl-L-leucyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]- (9CI);
Valeramide,2-(2-acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methyl-(8CI);
Acetyl-L-leucyl-L-leucylargininal;
LeuPeptin Ac-LL

L-Arginine,N-acetyl-L-leucyl-L-leucyl-;
Arginine,N2-[N-(N-acetyl-L-leucyl)-L-leucyl]-, L- (8CI);
L-Arginine,N2-[N-(N-acetyl-L-leucyl)-L-leucyl]-;
LeuPeptin acid;
N-Acetyl-L-leucyl-L-leucyl-L-arginine

L-Leucinamide,N-acetyl-L-leucyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]-;
L-Leucinamide,N-acetyl-L-leucyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]-, (S)-;
Acetyl-L-leucyl-L-leucyl-L-argininal;
LeuPeptin

Norleucine,6-diazo-5-oxo-N-2-propen-1-ylnorleucyl-6-diazo-5-oxo-;
AlazoPeptin(6CI,7CI,8CI);
Norleucine, 6-diazo-5-oxo-N-2-propenylnorleucyl-6-diazo-5-oxo-(9CI);
Norleucine, 6-diazo-N-(6-diazo-5-oxo-N-2-propenylnorleucyl)-5-oxo-

Permetin A (9CI);
PolyPeptinA, 9-L-serine-;
1-Oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontane,cyclic peptide deriv.;
9-L-SerinepolyPeptin A;
L-Serine,N2-(3-hydroxy-4-methyl-1-oxohexyl)-L-2,4-diaminobutanoyl-L-isoleucyl-L-2,4-diaminobutanoyl-D-phenylalanyl-L-leucyl-L-2,4-diaminobutanoyl-D-valyl-L-leucyl-,e1-lactone;
Permycin A

QuinaldoPeptin (9CI);
Tetrapyrido[1,2-a:1',2'-j:1'',2''-q:1''',2'''-z][1,4,7,10,13,17,20,23,26,29]decaazacyclodotriacontine,cyclic peptide deriv.;
Cyclo[N2-[(3-hydroxy-2-quinolinyl)carbonyl]-D-erythro-2,3-diaminobutanoyl-L-2-piperidinecarbonylglycyl-N-methylglycyl-L-2-piperidinecarbonyl-N2-[(3-hydroxy-2-quinolinyl)carbonyl]-D-erythro-2,3-diaminobutanoyl-L-2-piperidinecarbonylglycyl-N-methylglycyl-L-2-piperidinecarbonyl]

C62H78N14O14

詳情

供應(yīng)商

化工產(chǎn)品